loadpatents
name:-0.023916959762573
name:-0.023152112960815
name:-0.0059010982513428
Foulkes; J. Gordon Patent Filings

Foulkes; J. Gordon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Foulkes; J. Gordon.The latest application filed is for "formulations for substituted 3-pyrrolidines, compositions containing, and uses of, same".

Company Profile
5.20.25
  • Foulkes; J. Gordon - Rancho Santa Fe CA
  • Foulkes; J. Gordon - Encinitas CA
  • Foulkes; J. Gordon - Huntington Station NY
  • Foulkes; J. Gordon - Huntington NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Formulations For Substituted 3-pyrrolidines, Compositions Containing, And Uses Of, Same
App 20200306248 - Beeley; Nigel R.A. ;   et al.
2020-10-01
Method Of Treating Keloids Or Hypertrophic Scars Using Antisense Compounds Targeting Connective Tissue Growth Factor (ctgf)
App 20200190521 - Dean; Nicholas M. ;   et al.
2020-06-18
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
App 20190323013 - Dean; Nicholas M. ;   et al.
2019-10-24
12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME
App 20180185325 - Beeley; Nigel Robert Arnold ;   et al.
2018-07-05
12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME
App 20180179174 - Beeley; Nigel Robert Arnold ;   et al.
2018-06-28
Beta-naphthoisoflavones, Compositions Containing, And Uses Of, Same
App 20180118707 - Beeley; Nigel Robert Arnold ;   et al.
2018-05-03
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
App 20170335329 - Dean; Nicholas M. ;   et al.
2017-11-23
Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
Grant 9,688,987 - Dean , et al. June 27, 2
2017-06-27
Method Of Treating Keloids Or Hypertrophic Scars Using Antisense Compounds Targeting Connective Tissue Growth Factor (ctgf)
App 20170022501 - Dean; Nicholas M. ;   et al.
2017-01-26
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
App 20150376623 - Dean; Nicholas M. ;   et al.
2015-12-31
Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (CTGF)
Grant 9,173,894 - Dean , et al. November 3, 2
2015-11-03
Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
Grant 9,096,851 - Dean , et al. August 4, 2
2015-08-04
Methods for inhibiting expression of connective tissue growth factor
Grant 8,772,260 - Dean , et al. July 8, 2
2014-07-08
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
App 20130190380 - Dean; Nicholas M. ;   et al.
2013-07-25
Methods For Inhibiting Expression Of Connective Tissue Growth Factor
App 20130190382 - Dean; Nicholas M. ;   et al.
2013-07-25
Method Of Treating Keloids Or Hypertrophic Scars Using Antisense Compounds Targeting Connective Tissue Growth Factor (ctgf)
App 20120238937 - Dean; Nicholas M. ;   et al.
2012-09-20
Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
Grant 8,252,762 - Dean , et al. August 28, 2
2012-08-28
Modulation Of Smad3 Expression
App 20110213011 - Dean; Nicholas M. ;   et al.
2011-09-01
Modulation Of Transforming Growth Factor-beta 1 Expression
App 20110172296 - Bennett; C. Frank ;   et al.
2011-07-14
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
App 20100130595 - Dean; Nicholas M. ;   et al.
2010-05-27
Methods of discovering chemicals capable of functioning as gene expression modulators
App 20080009060 - Foulkes; J. Gordon ;   et al.
2008-01-10
Biological assays using coded RNA reporters
Grant 6,977,152 - Foulkes , et al. December 20, 2
2005-12-20
Assays with primary cells
App 20050084914 - Foulkes, J. Gordon ;   et al.
2005-04-21
Methods of discovering chemicals capable of functioning as gene expression modulators
App 20030166281 - Foulkes, J. Gordon ;   et al.
2003-09-04
Methods Of Transcriptionally Modulating Gene Expression
App 20030138773 - FOULKES, J. GORDON ;   et al.
2003-07-24
Biological assays using coded RNA reporters
App 20030082608 - Foulkes, J. Gordon ;   et al.
2003-05-01
Methods of discovering chemicals capable of functioning as gene expression modulators
Grant 6,376,175 - Foulkes , et al. April 23, 2
2002-04-23
Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and use for cellular assays in drug discovery
App 20020025940 - Whitney, Michael A. ;   et al.
2002-02-28
Methods of transcriptionally modulating expression of viral genes and genes useful for production of proteins
Grant 6,165,712 - Foulkes , et al. December 26, 2
2000-12-26
Methods of specifically transcriptionally modulating the expression of gene of interest
Grant 6,136,779 - Foulkes , et al. October 24, 2
2000-10-24
Methods of transcriptionally modulating gene expression and of discovering chemicals capable as gene expression modulators
Grant 5,976,793 - Foulkes , et al. November 2, 1
1999-11-02
Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
Grant 5,871,724 - Iwata , et al. February 16, 1
1999-02-16
Methods of determining chemicals that modulate expression of genes associated with cardiovascular disease
Grant 5,846,720 - Foulkes , et al. December 8, 1
1998-12-08
Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
Grant 5,824,297 - Iwata , et al. October 20, 1
1998-10-20
Methods of transcriptionally modulating gene expression
Grant 5,776,502 - Foulkes , et al. July 7, 1
1998-07-07
Method of discovering chemicals capable of functioning as gene expression modulators
Grant 5,665,543 - Foulkes , et al. September 9, 1
1997-09-09
Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease
Grant 5,580,722 - Foulkes , et al. December 3, 1
1996-12-03
Method for obtaining bone marrow free of tumor cells using transforming growth factor .beta.3
Grant 5,262,319 - Iwata , et al. November 16, 1
1993-11-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed